Guidelines for Corticosteroid use in Treatment of DMD
The guideline development subcommittee of the American Academy of Neurology has provided an update to the 2005 treatment guidelines for use of corticosteroids (CS) in Duchenne muscular dystrophy (DMD).
Autor principal: | Vamshi K. Rao |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado em: |
Pediatric Neurology Briefs Publishers
2016-07-01
|
coleção: | Pediatric Neurology Briefs |
Assuntos: | |
Acesso em linha: | https://www.pediatricneurologybriefs.com/articles/1693 |
Registros relacionados
-
Outcome of Long-Term Corticosteroid Treatment in Duchenne Muscular Dystrophy
por: J Gordon Millichap
Publicado em: (2007-06-01) -
Analysis of DMD translocations
por: Cockburn, D, et al.
Publicado em: (1991) -
Variability and trends in corticosteroid use by male United States participants with Duchenne muscular dystrophy in the Duchenne Registry
por: Leslie Cowen, et al.
Publicado em: (2019-05-01) -
Interpretation of "Chinese guidelines for diagnosis and treatment of pseudohypertrophy muscular dystrophy"
por: Cheng ZHANG
Publicado em: (2018-07-01) -
Clinical study of DMD gene point mutation causing Becker muscular dystrophy
por: Ji-qing CAO, et al.
Publicado em: (2015-06-01)